Product NDC: | 0179-0050 |
Proprietary Name: | Acetazolamide |
Non Proprietary Name: | Acetazolamide |
Active Ingredient(s): | 500 mg/1 & nbsp; Acetazolamide |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0179-0050 |
Labeler Name: | KAISER FOUNDATION HOSPITALS |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040904 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100209 |
Package NDC: | 0179-0050-70 |
Package Description: | 30 CAPSULE, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (0179-0050-70) |
NDC Code | 0179-0050-70 |
Proprietary Name | Acetazolamide |
Package Description | 30 CAPSULE, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (0179-0050-70) |
Product NDC | 0179-0050 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Acetazolamide |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20100209 |
Marketing Category Name | ANDA |
Labeler Name | KAISER FOUNDATION HOSPITALS |
Substance Name | ACETAZOLAMIDE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient] |